David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.38% |
| 2 | Energy | 10.34% |
| 3 | Technology | 9.79% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Sabre
SABR
$860M
| $1.38M | ﹤0.01% |
+56,833
| New | +$1.22M |
|
2277
Scully Royalty
SRL
$89.2M
| $1.38M | ﹤0.01% |
68,030
-10,818
| -14% | -$253K |
|
|
RAI
2278
PUT
DELISTED
Reynolds American Inc
RAI
| $1.38M | ﹤0.01% |
40,000
-446,200
| -92% | -$15.6M |
|
2279
Northwest Bancshares
NWBI
$2.24B
| $1.38M | ﹤0.01% |
116,201
+68,998
| +146% | +$820K |
|
|
SMRT
2280
DELISTED
Stein Mart Inc
SMRT
| $1.38M | ﹤0.01% |
110,582
+6,381
| +6% | +$90.2K |
|
|
BKS
2281
DELISTED
Barnes & Noble
BKS
| $1.38M | ﹤0.01% |
88,462
-94,336
| -52% | -$1.48M |
|
|
RWT
2282
Redwood Trust
RWT
$583M
| $1.37M | ﹤0.01% |
76,873
+22,108
| +40% | +$429K |
|
2283
Sixth Street Specialty
TSLX
$1.79B
| $1.37M | ﹤0.01% |
79,810
+39,007
| +96% | +$685K |
|
2284
CALL
Zions Bancorporation
ZION
$9.89B
| $1.37M | ﹤0.01% |
50,900
-143,500
| -74% | -$3.76M |
|
|
FRM
2285
DELISTED
FURMANITE CORPORATION COM
FRM
| $1.37M | ﹤0.01% |
173,776
+69,850
| +67% | +$522K |
|
2286
PUT
Deere & Co
DE
$168B
| $1.37M | ﹤0.01% |
15,600
-249,300
| -94% | -$22.1M |
|
|
PTLA
2287
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.37M | ﹤0.01% |
36,050
+6,941
| +24% | +$238K |
|
|
NBIS
2288
PUT
Nebius Group N.V.
NBIS
$59.7B
| $1.36M | ﹤0.01% |
90,000
+39,900
| +80% | +$642K |
|
2289
CALL
Generac Holdings
GNRC
$11.7B
| $1.36M | ﹤0.01% |
28,000
-47,600
| -63% | -$2.27M |
|
|
ANAT
2290
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.36M | ﹤0.01% |
13,836
+7,440
| +116% | +$765K |
|
|
XENT
2291
DELISTED
Intersect ENT, Inc
XENT
| $1.36M | ﹤0.01% |
52,674
+22,162
| +73% | +$507K |
|
2292
AAR Corp
AIR
$5.49B
| $1.36M | ﹤0.01% |
44,303
-27,304
| -38% | -$809K |
|
2293
PUT
EQT Corp
EQT
$34B
| $1.36M | ﹤0.01% |
30,127
+18,370
| +156% | +$779K |
|
|
AUD
2294
DELISTED
Audacy, Inc.
AUD
| $1.36M | ﹤0.01% |
111,768
-11,881
| -10% | -$142K |
|
|
TYPE
2295
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.36M | ﹤0.01% |
41,592
+1,957
| +5% | +$60.6K |
|
2296
PUT
F5
FFIV
$23.1B
| $1.36M | ﹤0.01% |
11,800
-71,300
| -86% | -$8.39M |
|
2297
OraSure Technologies
OSUR
$257M
| $1.35M | ﹤0.01% |
206,862
+154,473
| +295% | +$1.28M |
|
|
ORIG
2298
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $1.35M | ﹤0.01% |
22
-4
| -15% | -$287K |
|
2299
Bank OZK
OZK
$5.38B
| $1.35M | ﹤0.01% |
+36,572
| New | +$1.3M |
|
2300
PUT
Cenovus Energy
CVE
$58B
| $1.35M | ﹤0.01% |
80,000
+10,000
| +14% | +$184K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $2.47B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 36% a quarter earlier, followed by Energy and Technology.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.